News
7 March 2019
Cambridge Cognition sales orders up 49% to £7.93m
Cambridge Cognition announced preliminary results for the year ended 31 December 2018 with sales orders up 49% to £7.93m.
Read on
31 January 2019
Cambridge Cognition announces first partnership in India
Cambridge Cognition has announced a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using the Company’s cloud-based CANTAB Connect platform.
Read on
14 November 2018
Cambridge Cognition signs new eCOA contracts
Cambridge Cognition today announced it has won a significant new phase IV clinical trial contract for use of its electronic clinical outcomes assessment (eCOA) platform, CANTAB Connect.
Read on
13 September 2018
NeuroVocalix platform ready for clinical trials
NeuroVocalix enables novel voice-based cognitive assessments to be delivered directly to patients through mobile and tele-health platforms, helping to improve outcomes in clinical trials, aid clinical decision-making and play an important role in the management of long-term conditions such as chronic pain.
Read on
1 August 2018
Healthy Amplified launch new population health platform with CANTAB technology
Healthy Amplified are using CANTAB® technology to expand their population health platform offering to adults.
Read on
28 June 2018
CANTAB technology selected for world’s largest dementia study
We are pleased to announce our partnership with Dementias Platform UK (DPUK), the world’s largest study group in dementia research formed to accelerate the development of effective, and ultimately preventative, treatments for diseases such as Alzheimer’s.
